| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 10/30/2012 | CA2669355C Guggulphospholipid methods and compositions |
| 10/10/2012 | CN101044155B Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 09/27/2012 | WO2012056201A3 Sulfonium ion based electrophilic reagents for monohalomethyl group transfer, their preparation and uses |
| 09/20/2012 | US20120238740 Non-polar and polar leaving groups |
| 08/01/2012 | CN102617692A Steroid compound, preparation method and use thereof |
| 07/11/2012 | CN102558273A Method for preparing fluticasone furoate |
| 06/21/2012 | WO2012079275A1 Method for preparing fluticasone furoate |
| 06/21/2012 | US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes |
| 06/14/2012 | US20120149670 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases |
| 06/07/2012 | WO2012029077A3 Process for preparing fluticasone propionate/furoate |
| 05/30/2012 | CN102482317A 17-羟基-17-五氟乙基-雌-4,9(10)-二烯-11-芳基衍生物、其制备方法及其用于治疗疾病的用途 17- hydroxy-17-pentafluoroethyl - Estrogen-4,9 (10) - dien-11 aryl derivatives, their preparation and their use for the treatment of diseases |
| 05/23/2012 | EP2044099B1 Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 05/09/2012 | CN102448978A Novel Glucocorticoid Receptor Agonists |
| 05/03/2012 | WO2012056201A2 Electrophilic reagents for monohalomethylation,their preparation and their uses |
| 04/19/2012 | US20120094969 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases |
| 04/04/2012 | EP2435462A1 Novel glucocorticoid receptor agonists |
| 04/03/2012 | CA2472650C Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex |
| 03/28/2012 | EP2432798A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 03/14/2012 | EP2428519A2 Process for the preparation of 17-vinyl- triflates as intermediates |
| 03/13/2012 | CA2584052C Process for the esterification of a carbothioic acid |
| 03/07/2012 | EP1709062B1 Exemestane and its intermediates and methods of making the same |
| 03/01/2012 | US20120053340 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 02/23/2012 | US20120046258 Novel crystalline pharmaceutical product |
| 02/22/2012 | EP2044098B1 Process for the preparation of 6-alpha ,9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-3-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl ester |
| 02/21/2012 | CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 01/25/2012 | EP2408798A1 Polymorphs of fluticasone furoate and processes for preparation thereof |
| 01/24/2012 | CA2163748C Methods and compositions for inducing sleep |
| 01/18/2012 | CN102325784A TGR5 modulators and method of use thereof |
| 01/10/2012 | CA2492079C Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids |
| 01/04/2012 | EP2402361A1 Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17-carbothioate and intermediates |
| 01/04/2012 | EP2402360A1 Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17-carbothioate and intermediates |
| 12/13/2011 | US8076474 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 12/08/2011 | WO2011151625A1 Methods and compounds for the preparation of monofluoromethylated biologically active organic compounds |
| 12/08/2011 | WO2011151624A1 Method for monofluoromethylation of organic substrates to prepare biologically active organic compounds |
| 11/16/2011 | EP1781683B1 Process for the preparation of 17-vinyl- triflates as intermediates |
| 11/02/2011 | CN101466723B Industrial process for the synthesis of 17a-acetoxy-11ss-[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 10/27/2011 | US20110262368 C21 thioethers as glucocorticoid receptor agonists |
| 10/26/2011 | CN102227441A Processes and intermediates for production of fulvestrant |
| 10/26/2011 | CN102225924A Photoacid generators and photoresists comprising same |
| 10/19/2011 | EP2376519A1 Tgr5 modulators and method of use thereof |
| 10/06/2011 | US20110245196 Novel sulfated oligosaccharide derivatives |
| 10/04/2011 | US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
| 09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 08/24/2011 | EP2360153A2 Photoacid generators and photoresists comprising same |
| 08/24/2011 | CN102164940A TGR5 modulators and methods of use thereof |
| 08/03/2011 | EP2350111A1 Processes and intermediates for the production of fulvestrant |
| 07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/27/2011 | EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 06/15/2011 | EP2332960A2 Cholate photoacid generators and photoresists comprising same |
| 06/15/2011 | CN102099368A C-21 thioethers as glucocorticoid receptor agonists |
| 06/07/2011 | CA2628607C Androgen synthesis inhibitors |
| 05/25/2011 | EP2324046A2 Tgr5 modulators and methods of use thereof |
| 05/24/2011 | US7947667 Aromatization; hydrolysis; deblocking, deprotecting; oxidation; for production of fulvestrant |
| 04/28/2011 | WO2011009531A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 04/28/2011 | US20110098260 Steroid Compounds and Formulations |
| 04/27/2011 | EP2313424A2 Anionic pregnane compounds, method for their producing and use of them |
| 04/21/2011 | US20110092473 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 03/31/2011 | WO2011003870A3 Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
| 03/09/2011 | EP2292588A1 Ceramide dimers and their use as medicine or cosmetic preparation |
| 03/03/2011 | US20110053902 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 02/23/2011 | EP2286818A1 Fulvestrant formulation |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/08/2011 | USRE42132 have special action with respect to tubulin polymerization inhibition and can be used for treating prostate cancer, breast cancer, colon cancer, non-small-cell-lung cancer, or primary dermal microvascular endothelial cell proliferation; 2-methoxy-17a-oxo-17a-homoestra-1,3,5(10)-trien-3-yl sulfamate |
| 01/27/2011 | WO2011009531A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 01/27/2011 | WO2009085880A8 C-21 thioethers as glucocorticoid receptor agonists |
| 01/27/2011 | DE102009034362A1 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten 17-hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl-derivatives, processes for their preparation and their use for the treatment of diseases |
| 01/27/2011 | CA2768407A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 01/20/2011 | CA2767470A1 Non-polar and polar leaving groups |
| 01/06/2011 | US20110003782 23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof |
| 12/29/2010 | EP2266573A1 Fulvestrant formulation |
| 12/02/2010 | WO2010136940A1 Novel glucocorticoid receptor agonists |
| 12/02/2010 | CA2760284A1 Novel glucocorticoid receptor agonists |
| 11/17/2010 | EP2251346A2 Process for preparing guggulsterones and guggulsterol |
| 11/16/2010 | CA2185123C Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |
| 10/27/2010 | CN101870719A Organic functional compound having disulfide chemical bond and steroids skeleton, preparation method thereof and use thereof |
| 10/06/2010 | EP2235035A2 C-21 thioethers as glucocorticoid receptor agonists |
| 09/29/2010 | EP1771462B1 A process for the preparation of 7-alpha-alkylated 19-norsteroids |
| 09/23/2010 | WO2010108107A1 Polymorphs of fluticasone furoate and processes for preparation thereof |
| 09/23/2010 | US20100240684 Minoxidil aqueous composition containing bile acid |
| 07/08/2010 | US20100174101 Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)- triene-3,17-beta-diol |
| 06/30/2010 | EP2202240A1 Compound |
| 06/17/2010 | US20100152437 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 06/17/2010 | US20100152149 Formulation |
| 06/17/2010 | US20100151002 Guggulphospholipid Methods and Compositions |
| 06/01/2010 | US7728157 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
| 06/01/2010 | US7727976 achieving prolonged therapeutic or prophylactic blood concentrations of a drug or active metabolite ; transportating through intestine walls |
| 05/27/2010 | WO2010059853A1 Tgr5 modulators and method of use thereof |
| 05/27/2010 | US20100130458 Polymorphs of fluticasone furoate and process for preparation thereof |
| 05/27/2010 | CA2744189A1 Tgr5 modulators and methods of use thereof |
| 05/26/2010 | EP2188299A2 A method for treating diabetes |
| 05/25/2010 | CA2402667C 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 05/14/2010 | WO2010052896A1 Preparation for local administration containing fluticasone propionate |
| 05/12/2010 | EP2183267A2 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl) nonyl]estra-1,3,5(10)-triene-3,17-beta-diol |
| 05/12/2010 | CN101085803B Androstane compound and its preparation method and application |
| 04/22/2010 | WO2010043404A1 Processes and intermediates for the production of fulvestrant |
| 04/22/2010 | WO2010016931A3 Polymorphs of fluticasone furoate and process for preparation thereof |